Frequency of Clinically Occult Intraepithelial and Invasive Neoplasia in Reduction Mammoplasty Specimens: A Study of 516 Cases

Abstract

Reduction mammoplasty is a frequently performed procedure for the treatment of macromastia and for the achievement of symmetry in breast cancer patients following lumpectomy. Slides from 516 consecutive bilateral reduction mammoplasties performed for macromastia over 15 years were reviewed. Among these, 92 (18%) low-risk ductal intraepithelial neoplasia/intraductal hyperplasia, 28 (5%) ductal intraepithelial neoplasia 1 (1 low-grade ductal carcinoma in situ, 11 atypical intraductal hyperplasia, and 16 flat type), 17 (3%) lobular intraepithelial neoplasia, and 1 (0.2%) tubular carcinoma were identified. The patients were categorized into 3 age groups: <40 (n = 352), 40 to 50 (n = 107), and over 50 years (n = 57); the frequency of the lesions increased with age. These data confirm the low frequency of clinically occult malignancies identified in reduction mammoplasty specimens and provide substantial information about the frequency of a variety of intraepithelial proliferations. Preoperative mammography, specimen orientation, and inking of margins with 1 color are advised when reduction mammoplasty is scheduled for women ≥ 40 years of age.

Keywords

reduction mammoplasty ductal intraepithelial neoplasia lobular intraepithelial neoplasia fibroadenoma tubular carcinoma

Get full access to this article

View all access options for this article.

References

American Society of Plastic Surgery. Plastic surgery procedural statistics. http://www.plasticsurgery.org/public_education/loader.cfm?url=/commonspot/security/getfile.cfm&PageID=17845 . Accessed 2006.

Jemal A. , Siegel R. , Ward E. , et al. Cancer statistics, 2006. CA Cancer J Clin. 2006;56:106-130.

Smigal C. , Jemal A. , Ward E. , et al. Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin. 2006;56:168-183.

Colwell AS , Kukreja J. , Breuing KH , et al. Occult breast carcinoma in reduction mammaplasty specimens: 14-year experience. Plast Reconstr Surg. 2004 ;113:1984-1988.

Dinner MI , Artz JS Carcinoma of the breast occurring in routine reduction mammaplasty. Plast Reconstr Surg. 1989;83:1042-1044.

Gottlieb JR , McKinney P. , Walkinshaw MD , et al. Occult breast carcinoma in patients undergoing reduction mammaplasty . Aesthetic Plast Surg. 1989;13:279-283.

Ishag MT , Bashinsky DY , Beliaeva IV , et al. Pathologic findings in reduction mammaplasty specimens. Am J Clin Pathol. 2003;120:377-380.

Jansen DA , Murphy M. , Kind GM , et al. Breast cancer in reduction mammoplasty: case reports and a survey of plastic surgeons. Plast Reconstr Surg. 1998;101:361-364.

10.

Kakagia D. , Fragia A. , Tsoutsos GD Reduction mammaplasty specimens and occult breast carcinomas. Eur J Surg Oncol. 2005;31:19-21.

11.

Keleher AJ , Langstein HN , Ames FC , et al. Breast cancer in reduction mammaplasty specimens: case reports and guidelines. Breast J. 2003;9:120-125.

12.

Snyderman RK , Lizardo JG Statistical study of malignancies found before, during, or after routine breast plastic operations. Plast Reconstr Surg. 1960;25:253-256.

13.

Tang CL , Brown MH , Levine R. , et al. Breast cancer found at the time of breast reduction. Plast Reconstr Surg 1999;103:1682-1686.

14.

Tavassoli FA Ductal carcinoma in situ: introduction of the concept of ductal intraepithelial neoplasia. Mod Pathol. 1998;11:140-154.

15.

Tavassoli FA Ductal intraepithelial neoplasia (IDH, AIDH and DCIS). Breast Cancer. 2000;7:315-320.

16.

Tavassoli FA Ductal intraepithelial neoplasia of the breast . Virchows Arch. 2001;438:221-227.

17.

Tavassoli FA Breast pathology: rationale for adopting the ductal intraepithelial neoplasia (DIN) classification. Nat Clin Pract Oncol. 2005;2:116-117.

18.

Tavassoli FA , Devilee P , eds. World Health Organization Classification of Tumours, Pathology & Genetics Tumors of the Breast and Female Genital Organs. Lyon, France : IARC Press; 2003.

19.

Tavassoli FA , Norris HJ A comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast . Cancer. 1990; 65:518-529.

20.

Green F. , Page D. , Fleming I. , et al. American Joint Committee on Cancer Staging Manual , New York, NY: Springer; 2002.

21.

Anan K. , Mitsuyama S. , Tamae K. , et al. Tubular carcinoma of the breast: a histologic subtype indicative of breast-conserving therapy. Surg Today. 2000;30:1057-1061.

22.

Lagios MD , Rose MR , Margolin FR Tubular carcinoma of the breast: association with multicentricity, bilaterality, and family history of mammary carcinoma. Am J Clin Pathol. 1980;73:25-30.

23.

Hoogerbrugge N. , Bult P. , Bonenkamp JJ , et al. Numerous high-risk epithelial lesions in familial breast cancer. Eur J Cancer. 2006 ;42:2492-2498.

24.

Baasch M. , Nielsen SF , Engholm G. , et al. Breast cancer incidence subsequent to surgical reduction of the female breast. Br J Cancer. 1996;73:961-963.